Results 161 to 170 of about 28,625 (193)

No. 208

  +4 more sources

ID: 208

Cytokine, 2015
Judith Verhelst, Jan Spitaels, Cindy Nürnberger, Dorien De Vlieger, Tine Ysenbaert, Peter Staeheli, Walter Fiers, Xavier Saelens   +7 more
openaire   +1 more source

A = 206 - 208

2005
K. Way, N. B. Gove, C. L. McGinnis, R. Nakasima   +3 more
openaire   +1 more source

miR-208-Induced Epithelial to Mesenchymal Transition of Pancreatic Cancer Cells Promotes Cell Metastasis and Invasion

Cell Biochemistry and Biophysics, 2014
Anan Liu, Chenghao Shao, Gang Jin
exaly  

Supplement 208

BMJ, 1908
openaire   +1 more source

Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease

Movement Disorders, 1989
P G Jenner, C D Marsden, A M Bonnet
exaly  

miR-208-3p promotes hepatocellular carcinoma cell proliferation and invasion through regulating ARID2 expression

Experimental Cell Research, 2015
Yu You, Ping Bie
exaly  

Selective BET inhibitor RVX‐208 ameliorates periodontal inflammation and bone loss

Journal of Clinical Periodontology, 2023
exaly  

CY 208–243 behaves as a typical D-1 agonist in the reserpine-treated mouse

Pharmacology Biochemistry and Behavior, 1991
B S Starr, M S Starr
exaly  

RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease

Atherosclerosis, 2016
Sylwia Wasiak, Laura M Tsujikawa, Christopher Halliday   +2 more
exaly